PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-20

Date Title Company
20-Oct-2025 GE HealthCare collaborates with two major medical systems to advance AI technology designed to transform hospital operations and improve patient care Businesswire
20-Oct-2025 NFL Biosciences Outlines Its Development Plan for NFL-101 in Smoking Cessation Following Receipt of Scientific Advice From Several European Agencies and the U.S. FDA Businesswire
20-Oct-2025 Biopharmaceuticals Contract Manufacturing Market Report 2025-2035 | Tech Innovations and Emerging Markets Drive CMO Expansion Globally - ResearchAndMarkets.com Businesswire
20-Oct-2025 Vaccine Logistics Global Strategic Research Report 2025-2030: Global Campaigns Throw the Spotlight on Scalable and Resilient Vaccine Logistics Infrastructure - ResearchAndMarkets.com Businesswire
20-Oct-2025 Forrester Honors Recipients Of Its 2025 Technology Awards For North America Businesswire
20-Oct-2025 Rhythio Medical Receives FDA Breakthrough Device Designation for Injectable Electrode Technology Enabling Painless, Imperceptible Defibrillation Businesswire
20-Oct-2025 Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence Businesswire
20-Oct-2025 Newly Published Paper Describes Discovery that Powers Enzymatic Makeovers for GLP 1 Like Peptides Sethera Therapeutics
20-Oct-2025 IDWeek 2025: Shionogi Presents Real-World and Surveillance Data Reinforcing Role of Cefiderocol Across Range of Patient Populations and Difficult-to-Treat Infections Businesswire
20-Oct-2025 Prolong Pharmaceuticals to Present Phase 1/2 Data from HEMERA-1 for PP-007 in Acute Ischemic Stroke (AIS) at the 2025 World Stroke Conference (WSC) Businesswire
20-Oct-2025 OX40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms and Market Opportunity Insight 2026 - ResearchAndMarkets.com Businesswire
20-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
20-Oct-2025 Innoviva Specialty Therapeutics Announces Oral Presentation Featuring New Analyses from the Zoliflodacin Pivotal Phase 3 Trial at IDWeek 2025 Businesswire
20-Oct-2025 Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Businesswire
20-Oct-2025 Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities Businesswire
20-Oct-2025 Biogenesis Emerges from Stealth to Accelerate Clinical Trials for Pharmaceutical Industry Businesswire
20-Oct-2025 bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025 Businesswire
20-Oct-2025 Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025 Businesswire
20-Oct-2025 Valink Therapeutics Closes $11.8 Million Pre-A Financing Round to Advance Oncology Pipeline Businesswire
20-Oct-2025 Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress Businesswire